ÈÕ±¾ÎÞÂë

In this section :

Infections due to Clostridium difficile, MRSA or VRE: References

​Association for Professionals in Infection Control and Epidemiology (APIC).ÌýÌýAPIC Implementation Guide: Guide to preventing Clostridium difficile infections. Washington DC: APIC; 2013. Available at:Ìý

Calfee DP. Methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci, and other Gram-positives in healthcare.ÌýÌýCurr Opin Infect Dis.Ìý2012; 25(4): 385-394. doi: 10.1097/QCO.0b013e3283553441

Campbell EA. Outbreak investigations. In: APIC Text of Infection Control and Epidemiology Online (ATO). Arlington, VA: Association for Professionals in Infection Control and Epidemiology, INC. (APIC); 2014.Ìý

Canadian Patient Safety Institute (CPSI). How to help prevent healthcare-associated infections: A patient and family guide. Edmonton, AB: CPSI; 2012. https://www.patientsafetyinstitute.ca/en/About/Programs/HH/Documents/Patients%20and%20Families/Patient%20Family%20Guide.pdf

Centers for Disease Control and Prevention (CDC).Ìý. CDC; 2016.Ìý

Centers for Disease Control and Prevention.ÌýÌý

Centers for Disease Control and Prevention.ÌýVRE in healthcare settings. CDC; 2011.Ìý

Health Standards Organization (HS0).ÌýLeading Practices Toronto East General Antimicrobial Stewardship Program (ASP). Health Standards Organization; 2012 https://healthstandards.org/leading-practice/toronto-east-general-antimicrobial-stewardship-program-asp/

Health Standards Organization (HS0). Leading Practices Volunteers and Patients as Hand Hygiene "Partners in Care". Health Standards Organization; 2014Ìý

Institute for Healthcare Improvement (IHI).ÌýHow-to guide: Prevent catheter-associated urinary tract infections. Cambridge, MA: IHI; 2011. Available atÌý:ÌýÌý

Martin, P., C. Abou, V. William, K. Bush, M. Dyck, Z. Hirji et al. 2019. Prevalence of Antibiotic-Resistant Organisms in Canadian Hospitals. Comparison of Point-Prevalence Survey Results from 2010, 2012, and 2016. Infection Control and Hospital Epidemiology 40(1): 53–59. doi:10.1017/ice.2018.279.

McDonald LC, Gerding DN, Johnson S, et al. Clinical practice guidelines forÌýClostridium difficileÌýinfection in adults and children: 2017 update by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA).ÌýClin Infect Dis.Ìý2018; 66(7): 987-994. doi:10.1093/cid/cix1085. Available at:Ìý

Mitchell R, G. Taylor, W. Rudnick, S. Alexandre, K. Bush, L. Forrester et al. 2019. Trends in Health Care-Associated Infections in Acute Care Hospitals in Canada: An Analysis of Repeated Point-Prevalence Surveys.ÌýCMAJ;191 (36): E981–88. doi:10.1503/cmaj.190361.

National Institute for Health and Care Excellence (NICE).ÌýClostridium difficile infection: Risk with broad-spectrum antibiotics.ÌýNICE Evidence Summary; 2015.ÌýAvailable at:ÌýÌýÌý

Public Health Agency of Canada (PHAC).ÌýRoutine practices and additional precautions for preventing the transmission of infection in healthcare settings. Ottawa, ON: PHAC; 2017. Available at:Ìý

Public Health Agency of Canada (PHAC).ÌýTackling antimicrobial resistance and antimicrobial use: A pan-Canadian framework for action.ÌýOttawa, ON: PHAC; 2017. Available at:Ìý

Public Health Agency of Canada (PHAC). ÌýÌýFederal action plan on antimicrobial resistance and use in Canada: Building on the Federal framework for action. Ottawa, ON: PHAC; 2015. Available at:Ìý

Public Health Agency of Canada (PHAC). ÌýÌýFact sheet -ÌýClostridium difficile (C. difficile). Ottawa, ON: PHAC;Ìý2014. Available at:Ìý

Public Health Agency of Canada (PHAC). ÌýFact Sheet - Vancomycin-resistant Enterococci (VRE). Ottawa, ON: PHAC;Ìý2010. Available at:Ìý

Public Health Agency of Canada (PHAC).ÌýFact Sheet - Methicillin-Resistant Staphylococcus aureus.ÌýOttawa, ON: PHAC; 2008. Available at:ÌýÌý

Review on Antimicrobial Resistance. Tackling drug-resistant infections globally: Final report and recommendations. UK; 2016. Available at:Ìý

World Health Organization (WHO). News release.ÌýIn the face of slow progress, WHO offers a new tool and sets a target to accelerate action against antimicrobial resistance.ÌýWHO. Geneva. 2019.Ìý Available at:Ìý

World Health Organization (WHO).ÌýGuidelines on core components of infection prevention and control programmes at the national and acute health care facility level. WHO; 2016. Available at:Ìý

image_banner
Infections due to Clostridium difficile, MRSA or VRE

Back to Overview

image_banner
Infections due to Clostridium difficile, MRSA or VRE

Back to Overview